سعر ويستسليب Westsleep‏ 3مجم 30 قرص 2026

Westsleep 3 mg film-coated tablets containing eszopiclone, a non-benzodiazepine hypnotic used for insomnia, by Western Pharmaceuticals Industries, Egypt.

• Most common (incidence >=2%): unpleasant taste, headache, somnolence, respiratory infection, dizziness, dry mouth, rash, anxiety, hallucinations and viral infections.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Patients who have experienced complex sleep behaviors after taking eszopiclone.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Known hypersensitivity to eszopiclone (reactions include anaphylaxis and angioedema).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: complex sleep behaviors (sleep-walking, sleep-driving and other activities while not fully awake) may occur and can cause serious injury or death; discontinue immediately if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• CNS depressant effects and next-day impairment of driving and alertness, greater at 2-3 mg; additive with other CNS depressants.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Withdrawal symptoms may occur with rapid dose reduction or discontinuation; take immediately before bedtime.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• CNS depressants (benzodiazepines, opioids, tricyclic antidepressants, alcohol)Additive CNS depression; consider dose reduction of eszopiclone and the other depressant.DailyMed (U.S. National Library of Medicine)
• Potent CYP3A4 inhibitors (e.g. ketoconazole)Increase eszopiclone exposure; dose should not exceed 2 mg.DailyMed (U.S. National Library of Medicine)

• Available pharmacovigilance data are insufficient to identify a drug-associated risk of major birth defects, miscarriage or adverse outcomes; no teratogenicity in rat and rabbit studies.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human or animal milk or effects on the breastfed infant; weigh benefits of breastfeeding against maternal need and potential infant effects.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Eszopiclone: Acts at the benzodiazepine binding site of GABA-A receptors, enhancing GABAergic inhibition (directory pharmacology note; US label).